financetom
Business
financetom
/
Business
/
Housing Stocks Are On The Rise Today: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Housing Stocks Are On The Rise Today: What's Going On?
Jan 27, 2025 2:06 PM

Shares of housing stocks including NVR Inc. ( NVR ) and D.R. Horton Inc. ( DHI ) traded higher on Monday, likely driven by a better-than-expected report on U.S. new home sales for December.

What To Know: According to Reuters, the U.S. Commerce Department reported new home sales increased 3.6% to a seasonally adjusted annual rate of 698,000 units in December, exceeding economists’ expectations of 675,000 units. This marked a 6.7% year-over-year increase and contributed to a total of 683,000 new homes sold in 2024, a 2.5% gain from 2023. The median new home price rose 2.1% from the prior year to $427,000, although rising inventory appears to be tempering price growth.

This data potentially indicates sustained momentum in the housing market despite high mortgage rates, which have constrained activity overall. Builders are responding by constructing smaller, more affordable homes to attract buyers, while the inventory of new homes reached 494,000 units in December—the highest level since 2007. Notably, 118,000 homes were completed, the most since 2009.

Both companies operate as real estate investment trusts (REITs) focused on essential infrastructure, such as cell towers, which benefit indirectly from increased housing development and connectivity demands in growing residential areas. Rising demand for new housing may also spur further investments in telecommunications infrastructure, fueling optimism among investors about these stocks’ long-term growth potential.

Price Action: NVR shares closed up 2.22% at $8,382.63 and D.R. Horton ( DHI ) shares closed up 3.05% at $147.26 at the time of publication Monday, according to Benzinga Pro.

Read Next:

Newmont Completes $425 Million Asset Sale, Focuses On British Columbia Growth

Image Via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved